Felip E - Search Results

1

SEOM guidelines for the management of non-small-cell lung cancer (NSCLC).

Felip E, Garrido P, Trigo JM, López-Brea M, Paz-Ares L, Provencio M, Isla D; Spanish Society of Medical Oncology. Felip E, et al. Clin Transl Oncol. 2009 May;11(5):284-9. doi: 10.1007/s12094-009-0356-4. Clin Transl Oncol. 2009. PMID: 19451061

2

Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.

Felip E, Del Campo JM, Bodi R, Vera R, Casado S, Rubio D. Felip E, et al. Am J Clin Oncol. 1997 Aug;20(4):404-6. doi: 10.1097/00000421-199708000-00017. Am J Clin Oncol. 1997. PMID: 9256899 Clinical Trial.

3

A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.

Rosell R, Felip E, Massuti B, González-Larriba JL, Benito D, López-Cabrerizo MP, Salamanca O, Camps C, Puerto-Pica J. Rosell R, et al. Among authors: felip e. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-56-S12-60. Semin Oncol. 1997. PMID: 9331123 Clinical Trial.

4

Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.

Felip E, Massuti B, Camps C, Benito D, Isla D, González-Larriba JL, López-Cabrerizo MP, Salamanca O, Puerto-Pica J, Moyano A, Baselga J, Rosell R. Felip E, et al. Clin Cancer Res. 1998 Nov;4(11):2723-8. Clin Cancer Res. 1998. PMID: 9829735 Clinical Trial.

5

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

Monzó M, Rosell R, Felip E, Astudillo J, Sánchez JJ, Maestre J, Martín C, Font A, Barnadas A, Abad A. Monzó M, et al. Among authors: felip e. J Clin Oncol. 1999 Jul;17(7):2100-4. doi: 10.1200/JCO.1999.17.7.2100. J Clin Oncol. 1999. PMID: 10561264

6

Role of multimodality treatment for lung cancer.

Rosell R, Felip E. Rosell R, et al. Among authors: felip e. Semin Surg Oncol. 2000 Mar;18(2):143-51. doi: 10.1002/(sici)1098-2388(200003)18:2<143::aid-ssu8>3.0.co;2-i. Semin Surg Oncol. 2000. PMID: 10657916 Review.

7

Is the evidence in favour of neoadjuvant chemotherapy in stage IIIA (N2) non-small cell lung cancer solid enough?

Felip E, Rosell R. Felip E, et al. Monaldi Arch Chest Dis. 2000 Aug;55(4):305-10. Monaldi Arch Chest Dis. 2000. PMID: 11057084 Review.

8

Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer.

Isla D, Rosell R, Sánchez JJ, Carrato A, Felip E, Camps C, Artal A, González-Larriba JL, Azagra P, Alberola V, Martin C, Massutí B; Spanish Lung Cancer Group. Isla D, et al. Among authors: felip e. J Clin Oncol. 2001 Feb 15;19(4):1071-7. doi: 10.1200/JCO.2001.19.4.1071. J Clin Oncol. 2001. PMID: 11181671 Clinical Trial.

9

Neoadjuvant chemotherapy in non-small cell lung cancer: a standard approach?

Felip E. Felip E. Tumori. 2000 Sep-Oct;86(5 Suppl 1):S51-5. Tumori. 2000. PMID: 11195296 Review. No abstract available.

10

Novel approaches in the treatment of non-small-cell lung cancer.

Rosell R, Sánchez JM, Tarón M, O'Brate A, Gutiérrez JL, Monzó M, Felip E, Sánchez JJ, Alberola V. Rosell R, et al. Among authors: felip e. Oncology (Williston Park). 2001 Mar;15(3 Suppl 6):52-60. Oncology (Williston Park). 2001. PMID: 11301850 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

578 results

Search Page

Filters